Arzneimittel-Rabattvereinbarung für Oralair

AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen·Dresden, Germany·Deadline Aug 31, 2028 · 665 days left·Open·Supplies

Registrieren zum Speichern Open documents

Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

43/100

Opportunity Score

Needs reviewHigh complexity

SuppliesOpen

Warum diese Bewertung?

Chance

43 / 100

Komplexität

67 / 100

Risikofaktoren

The authority expressly states that demand and purchase quantities are unknown and that minimum quantities are not guar...

The authority may terminate the open-house procedure early, particularly after exclusive rebate agreements are conclude...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber: AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen
Land: Deutschland
CPV: 33600000 - Pharmaceutical products
Frist: Aug 31, 2028

Überblick

Moderate opportunity

Wichtige Fakten

Supplies contract
1 lot
Duration until Aug 2028
Conclusion of non-exclusive pharmaceutical rebate agreements under § 130a(8) SGB V for Oralair (ATC V01AA02).
Scope includes corresponding parallel imports and re-imports.

Vollständige Zusammenfassung anzeigen

Open-house framework-style pharmaceutical rebate arrangement for Oralair (ATC V01AA02), including parallel and re-imported products, offered by AOK PLUS in Germany. Participation is open to eligible pharmaceutical entrepreneurs meeting the stated conditions, without negotiations or exclusivity. Demand and purchases are not guaranteed, rebate terms are contained in restricted participation documents, and the procedure may end early if exclusive agreements are concluded.

Risiken

The authority expressly states that demand and purchase quantities are unknown and that minimum quantities are not guar...

The authority may terminate the open-house procedure early, particularly after exclusive rebate agreements are conclude...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

Participation is limited to pharmaceutical entrepreneurs within the meaning of § 4(18) AMG in relation to the offered medicinal products.
The participant must accept the fixed open-house contractual conditions; individual contract negotiations are not conducted.

Eligibility

An executed declaration confirming the absence of mandatory and optional exclusion grounds under §§ 123 and 124 GWB is required.

Auftraggeber

Name

AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen

Ort

Dresden, DEU

E-Mail

[email protected]

Website

www.aok.de/pk/plus/

Auftraggeberprofil

Profil öffnen

Kennung

DE256878834

Tätigkeit

Health

Lose (1)

LOT-0001

Oralair Pharmaceutical Rebate Agreement

Non-exclusive rebate agreement under § 130a(8) SGB V for Oralair (ATC V01AA02), including parallel and re-imported products, under an open-house model. No minimum purchase quantity is guaranteed. The lot information is based on structured tender data and the XML notice.

SuppliesFrameworkEU fundedElectronic submission

Ort

Dresden, Germany

Dauer

Aug 2026 - Aug 2028

Kategorie

Pharmaceutical products

Frist

Deadline Aug 31, 2028

Vergabedetails

Veröffentlichungsdatum: 09 Jul 2026
Sprachen: German

Referenzmetadaten

Rechtsgrundlage: 32014L0024

Referenz-IDs

Ausschreibungs-ID: 477144-2026

Dokumente (1)

Vergabedokument 1